Effect of a Recombinant Human Soluble Thrombomodulin on Baseline Coagulation Biomarker Levels and Mortality Outcome in Patients With Sepsis-Associated Coagulopathy

OBJECTIVES: To assess the effects of recombinant human soluble thrombomodulin treatment on 28-day all-cause mortality in subgroups categorized by baseline coagulation biomarker levels (prothrombin fragment 1.2, thrombin-antithrombin complex, d-dimer) in patients with sepsis-associated coagulopathy i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Crit Care Med
Egile Nagusiak: Levi, Marcel, Vincent, Jean-Louis, Tanaka, Kosuke, Radford, Amanda H., Kayanoki, Toshihiko, Fineberg, David A., Hoppensteadt, Debra, Fareed, Jawed
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2020
Gaiak:
Clinical Investigations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7365672/
https://ncbi.nlm.nih.gov/pubmed/32697484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCM.0000000000004426
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak